Department of Translational Research, New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy.
Endoscopy Service Division, University Hospital of Pisa, 56126 Pisa, Italy.
Int J Environ Res Public Health. 2021 Mar 3;18(5):2482. doi: 10.3390/ijerph18052482.
Failure in the reprocessing of thermolabile flexible endoscopes has been reported as one of the most important threats to patient health. A case report and observational study was conducted, from August 2014 to December 2019, in the Digestive Endoscopy Unit of a University Hospital in Italy, where two cases of Klebsiella pneumoniae carbapenemase ()-producing infections in patients undergoing endoscopic retrograde cholangio-pancreatography were observed. Following the risk/safety management practices, an epidemiological investigation was started, duodenoscopes were removed from use and the reprocessing practices reviewed. Moreover, microbiological surveillance of endoscopes was carried out according to the CDC guidelines. In the first phase of sampling, 10/10 (100%) endoscopes were found to be non-compliant, of which 7 showed results for high-concern organisms (HCOs), such as - and . After implementing corrective actions, 12 out of 17 endoscopes were found to be non-compliant (70.5%), of which 8 showed results for HCOs, such as and . During the last year of regular microbiological surveillance, only 23% of endoscopes (35/152) were found to be non-compliant, of which 7 showed results for HCOs, such as and . The crucial issues were related to samples collected from the internal channels of duodenoscopes. Managing the risk associated with the reprocessing of digestive endoscopes, through risk assessment at every stage of the process, is important for the prevention of infections associated with the use of these device.
据报道,不耐热软性内镜的再处理失败是威胁患者健康的最重要因素之一。2014 年 8 月至 2019 年 12 月,意大利某大学医院的消化内镜科进行了一项病例报告和观察性研究,在此期间,有 2 例接受内镜逆行胰胆管造影术的患者发生了产碳青霉烯酶肺炎克雷伯菌()感染。在遵循风险/安全管理实践的基础上,开展了流行病学调查,将十二指肠镜停用并重新评估再处理措施。此外,还根据美国疾病控制与预防中心(CDC)的指南进行了内镜微生物监测。在第一阶段的采样中,发现 10/10(100%)的内镜不符合要求,其中 7 个样本显示高度关注生物体(HCO),如和。在实施纠正措施后,17 个内镜中有 12 个(70.5%)不符合要求,其中 8 个样本显示 HCO,如和。在定期进行微生物监测的最后一年,只有 35/152(23%)个内镜不符合要求,其中 7 个样本显示 HCO,如和。关键问题与十二指肠镜内部通道采集的样本有关。通过在处理过程的每个阶段进行风险评估,对消化内镜的再处理相关风险进行管理,对于预防与这些器械使用相关的感染非常重要。